fesomersen

Bayer-Ionis' anti-thrombotic med doesn't increase bleeding in phase 2, setting stage for a new type of anticoagulant
Fierce Biotech
Thu, 07/28/22 - 05:54 pm
Bayer
Ionis Pharmaceuticals
kidney disease
clinical trials
fesomersen